è°è | éèè
èé°¨é
éè¨è¤°±éé¨ééè°·°±é¤§èèé°é§èè¤èèèèSPA¨
é駷è·èé°¤±é騱èè褤°èèèéèééé¤éè¤SPA訨1Cèèèéè§éè§è
515é¤èéè¤èè1200èéèè2600餧¨74.48%26.80è·èééè4
è¨éVCPE°¨èéèéè°±
èIPO褧èèè°è7152020·35·±§éèèèè35èèè±èéè°è
6é駰訰±
2020èIPO
¨è2020èè·35§éè駤è13¤è86é4°31
°è¨°°é1510è駰è§è§¨èèè餧¤èèèé
é6±éè··è·è¤±·10é¨6éè146
IPO°
§§¨°é訨°±IPO¨°é¨§¤¨èè°§è·
515é¤èéè¤èè1200èéèè2600è°è餧¨74.48%26.80è715è·33.4
é訰¨°è4é¨è(TAVR)§¨éèè觨¨é±è°èè¤èè°¨¨èèèéè°èèè·
1200é¨é70%èé¤éé1Cèèèèè¤è¤ééè°
éèé¤é±é¨è觧¨°éè
褧¨°¨¨°°§èèé豤èè跨褧 25¨§é91145.98é¨éè586.96%§é¨°éè717è·é¨è199¨2017--2019è2.242.863.670.330.650.822019é25.73
429,°é¤éè·12.6é¨è44%50¤è·28¨è°è717°è·éè220953.92
¨2017è2019è±9.49éè11.83±1.5è2.1°èèèè¤éé°¤§é2020è3.17077.43
è¤NGSéè¤NGSé¤è¨¤è¤é§è·è
612éè2014¨è¤··next generation sequencingNGSéé¤+é¨éè餤è°éè·èéèééé¤èé¤è¤èéèèéè¤èèèèè
è¤NGSèèèèè§èéèè··è°èééèGIC°è¤é¤èèèèIPO
éè褧è
è¨ééééèé±èè 2020·éèè·éèè55%§é
éé¤è餤§§··§èè··è餧¨è·±±
¨è35IPOé¤è°°°è4èèéé¤31è·¤èèèèèèè¤
èèééèèè·2020±IPO¤°é6éèè±IPOè··¤èIPO§·è§···
éèéèèè·¤±é°è¤·è5±IPOé±è訰跷··4IPOè觤éè°éè·3±IPOé
è±IPO
èèé
¨·ééè§éè
713éè¤è·10é谨褧èèè±èé¤
°è§è§¨¤§èééè館è駰éè§é¤é±·é駤éèéé¨è¤§èèèé°è¤¤±éèè§è§·°è¨°ééè騧éè
é·¨¤è§éèè°èèéèééè
è1989è§éé140¨¤§¨éèèé觨°èé èéèé
è¨è°èéèé°§èèèèèèèéè
é¤2020§·è§·6¤èèè¨è¤§éCOVID19°èéè°èPassage Bioè°èè
é
è·±è豧
°°èéè±éèè°°èCROCDMO§é§§§±éèPIPE§§°¤§°§¨±°éèé°¨CDMOCMO°¨¨°è§é騧è±
¨°è§¨°IVDèèèè±é¨°é¨·¤§°3D°è¨°¨±è許
¨è·è±è°§°§èè¨èèéè§è¨é°èèé±è¤éé
éèèè褱°¨é
¨éé騰èèè·é騧é駧§éè°èééè§Me-better/First-in-class §°è¨èè°èéé§é°é¨
¨èé¨/èPOCTèè°°IVD°¤§é¨è鱨±éèé±°éé±±è§èè§è¨ééè±é±é鱨POCT°·è
¨é¨°èéè¨é¨°
¤¤è±°é觨訨谰·±°°è··èéé鰰訷éè§ééè¨è¨§é§è±¤§è
éè跨豰è·è±5G·è¨é°§è°¨èèèè¨è¤èèè餰è豤§è·è¤·é
¨éVCPE餧è¨IPOèé¨è§é
éèèè°
è·éè·èwujinna1015
è§PRèèè·èrenguozhou2019
¤¤è·èliuxiao201492
èèè·èliuxiao201492
è·¨è±